8-Aminoquinoline → HCID 68183375, 화합물
반응식
[NH2:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[N:10]=[CH:9][CH:8]=[CH:7]2.[F:12][C:13]1[C:14]([CH3:23])=[C:15]([S:19](Cl)(=[O:21])=[O:20])[CH:16]=[CH:17][CH:18]=1>CN(C1C=CN=CC=1)C>[F:12][C:13]1[C:14]([CH3:23])=[C:15]([S:19]([NH:1][C:2]2[CH:3]=[CH:4][CH:5]=[C:6]3[C:11]=2[N:10]=[CH:9][CH:8]=[CH:7]3)(=[O:21])=[O:20])[CH:16]=[CH:17][CH:18]=1참가 물질
4
실험 절차
In a similar fashion using route 14 general procedure 27, 8-aminoquinoline (100 mg, 0.69 mmol), 3-fluoro-2-methylbenzenesulfonyl chloride (210 mg, 1.04 mmol) and DMAP (cat.) gave the title compound (120 mg, 57%) after purification by column chromatography with DCM eluent.
출처 및 근거
- ORD 기록
- ord-625faaf30c4147968ac3cfb2b19f0c6d
- 출처 데이터셋
- uspto-grants-2015_08
- 특허 번호
- US09102688B2
반응 노트
불러오는 중…